Nuvalent Inc vs Prologis Inc — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Prologis Inc trades at $151.05 (market cap $137.50B). The key difference: Prologis Inc is far larger — about 14× Nuvalent Inc's market cap, and Prologis Inc pays a 2.9% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | PLD | |
|---|---|---|
Market Cap | $9.81B | $137.50B |
Sector | Technology | Real Estate |
52-Week High | $123.96 | $149.96 |
52-Week Low | $72.16 | $104.08 |
Enterprise Value | $8.52B | $172.18B |
Dividend Yield | — | 2.9% |
Trailing returns across standard periods
Latest headlines on both assets
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $70 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.
Read more on PLD →